Status:
UNKNOWN
Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
Lead Sponsor:
Northfield Laboratories
Conditions:
Hemorrhagic Shock
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study is designed to assess the survival benefit of administering PolyHeme to severely injured trauma patients in hemorrhagic shock beginning in the prehospital setting, where blood is not availa...
Eligibility Criteria
Inclusion
- Adult patients following trauma who have sustained blood loss and are in shock
Exclusion
- Patients who have sustained unsurvivable injuries
- Patients who have severe head injury
- Pregnant females
- Patients found in cardiac arrest
- Patients who object to participation (e.g., religious grounds, wearing exclusion bracelet).
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00076648
Last Update
August 2 2006
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Mercy
San Diego, California, United States, 92103
2
UC San Diego Medical Center
San Diego, California, United States, 92103
3
Denver Health Medical Center
Denver, Colorado, United States, 80204
4
Christiana Hospital
Newark, Delaware, United States, 19718